chlorhexidine has been researched along with Keratitis, Acanthamoeba in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (13.79) | 18.2507 |
2000's | 22 (25.29) | 29.6817 |
2010's | 40 (45.98) | 24.3611 |
2020's | 13 (14.94) | 2.80 |
Authors | Studies |
---|---|
Chiu, LY; Lee, PY; Lin, CC | 1 |
Gupta, A; Khurana, S; Megha, K; Sehgal, R; Sharma, C; Sharma, M | 1 |
Cevallos, V; Elakkiya, S; Kamal, FS; Keenan, JD; Lietman, TM; Prajna, L; Prajna, NV; Rajaraman, R; Richardson, QR; Seitzman, GD; Talbott, M | 1 |
Hashim, F; Johari, SATT; Ma, NL; Rased, NM; Razali, SA; Zakeri, HA | 1 |
Kazemirad, E; Latifi, A; Mohebali, M; Rezaian, M; Soleimani, M; Yasami, S | 1 |
Dart, JKG; Minassian, DC; Papa, V; Radford, C; Rama, P | 1 |
Li, W; Qu, J; Sun, X; Wang, Z; Zhang, Y | 1 |
Anwar, A; Fatima, I; Khan, KM; Khan, NA; Siddiqui, R; Yi, YP | 1 |
Jang, SK; Jo, YJ; Lee, J; Lee, JS | 1 |
Anwar, A; Khan, NA; Siddiqui, R; Soomaroo, A | 1 |
Bagga, B; Garg, P; Gour, RPS; Joseph, J; M Rathi, V; Mohamed, A; Sharma, S | 1 |
Ghoshal, U; Kalra, SK; Sharma, G; Tejan, N | 1 |
Bagga, B; Garg, P; Gour, RPS; Joseph, J; Mohamed, A; Rathi, V; Sharma, S | 1 |
Iovieno, A; Yeung, SN | 1 |
Ferreira Mendes, J; Monteiro, T | 1 |
Abjani, F; Jung, SY; Khan, NA; Siddiqui, R | 1 |
de Araújo, BS; Dos Santos, DL; Kwitko, S; Locatelli, CI; Marinho, DR; Rott, MB | 1 |
Langenbucher, A; Seitz, B; Shi, L; Stachon, T; Szentmáry, N; Wagenpfeil, S | 1 |
Caro-Magdaleno, M; de Borja Domínguez-Serrano, F; Montero-Iruzubieta, J; Perea-Pérez, R; Rodríguez-de-la-Rúa, E | 1 |
Henry, MR; Pritt, BS; Starr, MR; Tan, EM | 1 |
Choi, HS; Kong, HH; Moon, EK; Quan, FS | 1 |
Bazzo, ML; Buchele, MLC; Casara, F; Caumo, KS; de Macedo, JP; Dos Reis Spada, F; Dos Santos, JI; Monteiro, FBF; Rott, MB; Wopereis, DB | 1 |
Brazil, NT; Maschio, VJ; Rott, MB; Schuh, RS; Teixeira, HF; Zorzi, GK | 1 |
Alcántara-Castro, M; Castelan-Ramírez, I; Flores-Alvarado, V; González-Robles, A; Hernández-Martínez, D; Hernández-Olmos, P; Lorenzo-Morales, J; Omaña-Molina, M; Ramírez-Flores, E; Reyes-Batlle, M; Salazar-Villatoro, L; Servín-Flores, C; Vanzzini-Zago, V | 1 |
Baltaza, W; Chomicz, L; Conn, DB; Padzik, M; Szaflik, JP | 1 |
Castelan-Ramírez, I; Hernández-Martínez, D; Hernández-Olmos, P; Lorenzo-Morales, J; Omaña-Molina, M; Piñero, JE; Ramírez-Flores, E; Reyes-Batlle, M; Sifaoui, I; Vanzzini-Zago, V | 1 |
Barua, A; Bhatti, A; Desai, R; Hassan, F | 1 |
Criado-Fornelio, A; de la Mata, FJ; Gómez, R; Lozano-Cruz, T; Martín-Pérez, T; Ortega, P; Pérez-Serrano, J | 1 |
Elkadery, AAS; Elsherif, EA; Ezz Eldin, HM; Fahmy, IAF; Mohammad, OS | 1 |
Ishibashi, Y; Kobayashi, A; Oikawa, Y; Sugiyama, K; Tokoro, M; Yamazaki, N; Yokogawa, H | 1 |
Connolly, J; Livingstone, I; Mantry, S; Moggach, S; Ramaesh, K; Ramamurthi, S; Stefanowicz, F | 1 |
Copa-Patiño, JL; de la Mata, FJ; Gómez, R; Heredero-Bermejo, I; Pérez-Serrano, J; Soliveri, J | 1 |
Abdel Aziz, S; Kowalski, RP; Nau, AC; Raju, LV; Romanowski, EG; Shanks, RM | 1 |
Petsoglou, C; Samarawickrama, C; Tran, T; Watson, S | 1 |
Carnt, N; Dart, JK; Minassian, DC; Robaei, D | 1 |
Huang, CF; Lin, CY; Lin, SC; Shen, LJ; Wang, HJ; Wu, FL | 1 |
Copa-Patiño, JL; de la Mata, FJ; Fuentes-Paniagua, E; Gomez, R; Heredero-Bermejo, I; Perez-Serrano, J; Soliveri, J | 1 |
Abou-Bacar, A; Bourcier, T; Candolfi, E; Letsch, J; Sauer, A | 1 |
Khan, NA; Lorenzo-Morales, J; Walochnik, J | 1 |
Alkharashi, M; Law, HA; Lindsley, K; Sikder, S | 1 |
Anwar, A; Aqeel, Y; Khan, NA; Shah, MR; Siddiqui, R | 1 |
Copa-Patiño, JL; de la Mata, FJ; Gómez, R; Heredero-Bermejo, I; Pérez-Serrano, J; Sánchez-Nieves, J; Soliveri, J | 1 |
Aqeel, Y; Khan, NA; Siddiqui, R | 1 |
Elsheikha, HM; Ortega-Rivas, A; Padrón, JM; Valladares, B | 1 |
Booton, GC; Joslin, CE; Shoff, ME; Sugar, J; Tu, EY | 1 |
Cabrera-Serra, MG; Coronado-Álvarez, NM; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Rancel, F; Valladares, B | 1 |
Gotay, A; Lee, WB | 1 |
Hara, Y; Ohashi, Y; Oka, N; Shiraishi, A; Uno, T; Yamaguchi, M | 1 |
Fernandes, M; Lakshmipathy, M; Shah, SG; Sharma, S | 1 |
Behrens, A; Castro-Combs, JM; Flikier, D; Kalyani, S; Kashiwabuchi, RT; Khan, YA; Martins, SA; Stanley, P | 1 |
Arnalich-Montiel, F; López-Arencibia, A; López-Vélez, R; Lorenzo-Morales, J; Maciver, SK; Martín-Navarro, CM; Martínez-Carretero, E; Morcillo-Laiz, R; Valladares, B | 1 |
Ohashi, Y | 1 |
Fukuda, M; Higaki, S; Itahashi, M; Mishima, H; Shimomura, Y | 1 |
Polat, ZA; Vural, A | 1 |
Shimazaki, J; Shimazaki-Den, S; Yamamoto, Y; Yamazoe, K | 1 |
Dart, JK; Hughes, R; Kilvington, S; Matheson, M; Pérez-Santonja, JJ; Tufail, A | 1 |
Lin, C; Ran, L; Shiyun, L; Xiuying, J; Xuguang, S; Yan, Z; Zhiqun, W | 1 |
Ehlers, N; Hjortdal, J | 1 |
Furr, JR; Hann, AC; Khunkitti, W; Lloyd, D; Russell, AD | 1 |
Seal, D | 1 |
Wilhelmus, KR | 1 |
Chen, W; Deng, S; Gao, M; Jin, X; Li, R; Luo, S; Sun, X; Wang, Z; Zhang, Y | 1 |
Altintas, O; Ay, GM; Cağlar, Y; Demirci, G; Karabas, LV; Tamer, GS | 1 |
Mathers, W | 1 |
Ho, TC | 1 |
Chung, DI; Jeong, HJ; Kong, HH; Lee, JE; Lee, JS; Lee, SJ; Ock, MS; Xuan, YH; Yu, HS | 1 |
Choi, HY; Hahn, TW; Lee, JE; Lee, JS; Oum, BS; Yu, HS | 1 |
Choi, SH; Chung, DI; Jeong, HJ; Kim, JH; Kong, HH; Lee, KH; Lee, SJ; Ock, MS; Park, SK; Xuan, YH; Yu, HS | 1 |
Bunce, C; Ficker, L; Fraenkel, G; Goh, D; Lim, N; Poole, TR; Xing, W | 1 |
Arici, MK; Cetin, A; Erdogan, H; Polat, ZA; Toker, MI; Topalkara, A; Vural, A | 1 |
Choi, SH; Hahn, TW; Lee, JE; Lee, JS; Yu, HS | 1 |
Brownstein, S; El-Defrawy, S; Gooi, P; Jackson, WB; Lee-Wing, M; Mintsioulis, G | 1 |
Herz, NL; Matoba, AY; Wilhelmus, KR | 1 |
Hay, J; Kirkness, CM; Seal, DV | 1 |
Hay, J; Kirkness, CM; Seal, DV; Wright, P | 1 |
Booth, A; Morrell, AJ | 1 |
Dart, JK; Elder, MJ | 1 |
Kilvington, S | 1 |
Byers, TJ; Hay, J; Kirkness, CM; Ledee, DR; Seal, DV | 1 |
Markus, MB; Niszl, IA | 1 |
Hay, J; Pyott, A; Seal, D | 1 |
Armstrong, M; Booth, A; Hay, J; Kirkness, C; Morrell, A; Ridgway, A; Seal, D; Tullo, A | 1 |
Cassella, JP; Hay, J; Seal, DV | 1 |
Kosrirukvongs, P; Visvesvara, GS; Wanachiwanawin, D | 1 |
Buck, SL; Rosenthal, RA; Schlech, BA | 1 |
Avni, I; Blank-Porat, D; Harizman, N; Keller, N; Wygnanski-Jaffe, T; Wysenbeek, YS | 1 |
K, LT; Madhavan, HN; Narasimhan, S | 1 |
6 review(s) available for chlorhexidine and Keratitis, Acanthamoeba
Article | Year |
---|---|
Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Amebicides; Biguanides; Central Nervous System Protozoal Infections; Chlorhexidine; Drug Delivery Systems; Immunocompetence; Immunocompromised Host; Infectious Encephalitis; Nanoparticles; Trophozoites | 2020 |
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adrenal Cortex Hormones; Amebicides; Animals; Biological Assay; Chlorhexidine; Corneal Transplantation; Cross-Linking Reagents; Diagnostic Techniques, Ophthalmological; Host-Parasite Interactions; Humans; Hydroxymercuribenzoates; Mice; Parasitology; Phagocytosis; Protozoan Proteins; Specimen Handling; Virulence | 2015 |
Medical interventions for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Humans; Randomized Controlled Trials as Topic | 2015 |
The Development of Drugs against Acanthamoeba Infections.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amphotericin B; Animals; Antiprotozoal Agents; Azoles; Biguanides; Caspofungin; Cefazolin; Chlorhexidine; Echinocandins; Humans; Infectious Encephalitis; Lipopeptides; Meropenem; Natamycin; Polymyxin B; Thienamycins | 2016 |
Treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Amebicides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Contact Lenses; Humans; Neomycin; Phosphorylcholine; Treatment Failure | 2003 |
Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Contact Lens Solutions; Contact Lenses; Drug Evaluation; Humans; Hydrogen Peroxide; Thimerosal | 2000 |
3 trial(s) available for chlorhexidine and Keratitis, Acanthamoeba
Article | Year |
---|---|
A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba k
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Prospective Studies; Voriconazole | 2021 |
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Biguanides; Chlorhexidine; Disinfectants; Double-Blind Method; Female; Humans; Male; Ophthalmic Solutions; Prospective Studies; Treatment Outcome; Visual Acuity | 2008 |
Treatment of acanthamoeba keratitis with chlorhexidine.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Aged; Animals; Anti-Infective Agents, Local; Chlorhexidine; Cornea; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Safety; Treatment Outcome; Visual Acuity | 1999 |
78 other study(ies) available for chlorhexidine and Keratitis, Acanthamoeba
Article | Year |
---|---|
Bilateral radial keratoneuritis resulting from acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Contact Lenses; Cornea; Disinfectants; Female; Humans; Photophobia | 2022 |
Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents; Chlorhexidine; Epithelium, Corneal; Fluconazole; Humans; Pentamidine; Polymyxin B; Water | 2022 |
Antiamoebic Susceptibility in Acanthamoeba Keratitis: Comparison of Isolates From South India and Northern California.
Topics: Acanthamoeba; Acanthamoeba Keratitis; California; Chlorhexidine; Humans; Voriconazole | 2023 |
Combinatorial treatment with β-glucanase enzyme and chlorhexidine induces cysticidal effects in Acanthamoeba cyst.
Topics: Acanthamoeba; Acanthamoeba Keratitis; beta-Glucans; Cellulose; Chlorhexidine; Glucans; Glutamates; Humans; Ligands; Molecular Docking Simulation; Xylans | 2022 |
Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents; Chlorhexidine; Chlorocebus aethiops; Cysts; Humans; Pentamidine; Trophozoites; Vero Cells | 2023 |
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Aged; Antiprotozoal Agents; Biguanides; Chlorhexidine; Disinfectants; Drug Therapy, Combination; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Pentamidine; Retrospective Studies; Visual Acuity; Young Adult | 2020 |
Acanthamoeba keratitis related to contact lens use in a tertiary hospital in China.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Infective Agents, Local; Biguanides; Child; China; Chlorhexidine; Contact Lenses; Corneal Ulcer; Disinfectants; DNA, Protozoan; Drug Combinations; Eye Infections, Parasitic; Female; Humans; Keratoplasty, Penetrating; Male; Microscopy, Confocal; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; RNA, Ribosomal, 18S; Tertiary Care Centers; Young Adult | 2019 |
Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebicides; Chlorhexidine; Genotype; HeLa Cells; Humans; Metal Nanoparticles; Silver; Tetrazoles | 2020 |
A 5-Year Review of Acanthamoeba Keratitis Related to Wearing Contact Lenses in Korea.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Antiprotozoal Agents; Chlorhexidine; Contact Lenses; Female; Guanidines; Humans; Male; Microscopy, Confocal; Polymers; Republic of Korea; Retrospective Studies; Risk Factors; Vision Disorders; Visual Acuity; Young Adult | 2020 |
Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Central Nervous System Protozoal Infections; Chlorhexidine; HeLa Cells; Humans; Infectious Encephalitis; Metal Nanoparticles; Metformin; Microscopy, Atomic Force; Parasite Encystment; Silver; Spectrophotometry, Ultraviolet; Trophozoites | 2020 |
Response to 'Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine in the t
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Voriconazole | 2022 |
Comment on: 'A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of A
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Humans; Ophthalmic Solutions; Voriconazole | 2022 |
Pseudodendritic ulcer.
Topics: Acanthamoeba Keratitis; Adolescent; Benzamidines; Chlorhexidine; Corneal Ulcer; Humans; Male; Tomography, Optical Coherence | 2017 |
Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Cellulase; Chlorhexidine; Contact Lens Solutions; Humans; Keratitis; Malaysia; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Streptococcus pneumoniae; Streptococcus pyogenes; Trichoderma | 2017 |
Acanthamoeba keratitis in Porto Alegre (southern Brazil): 28 cases and risk factors.
Topics: Acanthamoeba Keratitis; Adult; Benzamidines; Biguanides; Brazil; Chlorhexidine; Contact Lens Solutions; Contact Lenses; Female; Humans; Male; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
The Effect of Antiamoebic Agents on Viability, Proliferation and Migration of Human Epithelial Cells, Keratocytes and Endothelial Cells, In Vitro.
Topics: Acanthamoeba Keratitis; Anti-Infective Agents; Antiprotozoal Agents; Benzamidines; Cell Count; Cell Proliferation; Cell Survival; Cells, Cultured; Chlorhexidine; Corneal Keratocytes; Endothelium, Corneal; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Eye Infections, Parasitic; Humans; Pentamidine | 2018 |
Case Report: Acanthamoeba Keratitis Management in a First-trimester Pregnant Patient.
Topics: Acanthamoeba Keratitis; Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Benzamidines; Chlorhexidine; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Microscopy, Confocal; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Punctal Plugs; Visual Acuity | 2018 |
The Brief Case: A "Fresh" Pair of Contact Lenses.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Chlorhexidine; Contact Lenses; Cytological Techniques; Humans; Male; Microbiological Techniques; Ophthalmic Solutions; Polymerase Chain Reaction; Treatment Outcome | 2018 |
Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebicides; Biguanides; Cell Nucleus; Cells, Cultured; Chlorhexidine; Chloroquine; Culture Media; DNA Fragmentation; Epithelium, Corneal; Humans; Nitriles; Phosphatidylserines | 2018 |
Contact lens-related polymicrobial keratitis: Acanthamoeba spp. genotype T4 and Candida albicans.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Biguanides; Candida albicans; Candidiasis; Chlorhexidine; Contact Lenses; Cornea; DNA, Ribosomal; Female; Genotype; Humans; RNA, Ribosomal, 18S | 2018 |
Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Chlorhexidine; Cornea; Disease Models, Animal; Drug Administration Schedule; Drug Compounding; Drug Delivery Systems; Drug Therapy, Combination; Factor Analysis, Statistical; Fatty Acids, Monounsaturated; Gene Expression Regulation; Glycogen Phosphorylase; Humans; Liposomes; Phosphatidylethanolamines; Phosphoric Monoester Hydrolases; Polyethylene Glycols; Protozoan Proteins; Quaternary Ammonium Compounds; Rats; Rats, Wistar; RNA, Small Interfering; Trophozoites | 2019 |
Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Chlorhexidine; Contact Lenses; Dogs; Female; Humans; Inhibitory Concentration 50; Itraconazole; Madin Darby Canine Kidney Cells; Mexico; Mice; Mice, Inbred BALB C; Mydriatics; Netilmicin; Parasitic Sensitivity Tests; Phenylephrine; Tropicamide; Voriconazole | 2019 |
Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of
Topics: Acanthamoeba; Acanthamoeba Keratitis; Antiprotozoal Agents; Chlorhexidine; Genotype; Humans; Poland; Povidone-Iodine; Toyocamycin | 2018 |
Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Anti-Infective Agents; Chlorhexidine; Contact Lenses; Corneal Ulcer; DNA, Protozoan; Genotype; Humans; Inhibitory Concentration 50; Itraconazole; Mexico; Soil; Voriconazole | 2019 |
Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Contact Lenses; Disinfectants; DNA, Protozoan; Female; Hospitals, Teaching; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; United Kingdom; Visual Acuity; Young Adult | 2019 |
Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebicides; Animals; Biguanides; Cell Line, Tumor; Chlorhexidine; Contact Lens Solutions; Dendrimers; Encephalitis; HeLa Cells; Humans; Trophozoites | 2019 |
Efficient therapeutic effect of Nigella sativa aqueous extract and chitosan nanoparticles against experimentally induced Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Antiprotozoal Agents; Chitosan; Chlorhexidine; Cornea; Female; Humans; Male; Nanoparticles; Nigella sativa; Plant Extracts; Rats; Treatment Outcome | 2019 |
In vivo laser confocal microscopy findings of radial keratoneuritis in patients with early stage Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Antifungal Agents; Chlorhexidine; Contact Lenses, Hydrophilic; Cornea; Cranial Nerve Diseases; Debridement; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microscopy, Confocal; Neuritis; Ophthalmic Nerve; Prospective Studies; Risk Factors; Young Adult | 2013 |
New insight into non-healing corneal ulcers: iatrogenic crystals.
Topics: Acanthamoeba Keratitis; Aged; Chlorhexidine; Corneal Ulcer; Crystallization; Crystallography, X-Ray; Dexamethasone; Drug Combinations; Female; Humans; Iatrogenic Disease; Microscopy, Confocal; Timolol; Wound Healing; Young Adult | 2013 |
In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.
Topics: Acanthamoeba; Acanthamoeba castellanii; Acanthamoeba Keratitis; Antiprotozoal Agents; Chlorhexidine; Contact Lenses; Humans; Indicators and Reagents; Oxazines; Tetrazolium Salts; Thiazoles; Trophozoites; Xanthenes | 2013 |
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Humans; Parasitic Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2013 |
Recent cluster of childhood microbial keratitis due to orthokeratology.
Topics: Acanthamoeba Keratitis; Adolescent; Anti-Bacterial Agents; Biguanides; Cephalothin; Child; Chlorhexidine; Cluster Analysis; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Ofloxacin; Orthokeratologic Procedures; Pseudomonas Infections | 2014 |
The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Biguanides; Chlorhexidine; Cohort Studies; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Microscopy, Confocal; Middle Aged; Pentamidine; Treatment Outcome; Visual Acuity; Young Adult | 2014 |
Formulation and stability of an extemporaneous 0.02% chlorhexidine digluconate ophthalmic solution.
Topics: Acanthamoeba Keratitis; Chlorhexidine; Drug Compounding; Drug Stability; Humans; Ophthalmic Solutions; Time Factors | 2015 |
Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents, Local; Cell Membrane; Cell Survival; Chlorhexidine; Contact Lenses; Culture Media; Dendrimers; Flow Cytometry; HeLa Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Silanes; Trophozoites | 2015 |
[Evaluation of in vitro efficacy of combined riboflavin and ultraviolet-A (365 nm) for Acanthamoeba].
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Chlorhexidine; Humans; In Vitro Techniques; Microscopy; Parasite Encystment; Riboflavin; Ultraviolet Rays | 2015 |
Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Amebicides; Anti-Infective Agents, Local; Brain; Cells, Cultured; Chlorhexidine; Gold; Humans; Microscopy, Atomic Force; Nanoparticles; Neomycin; Silver; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Ultraviolet | 2015 |
In vitro anti-Acanthamoeba synergistic effect of chlorhexidine and cationic carbosilane dendrimers against both trophozoite and cyst forms.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Cations; Cell Line, Tumor; Chlorhexidine; Cysts; Dendrimers; Drug Synergism; HeLa Cells; Humans; Silanes; Trophozoites | 2016 |
Acanthamoeba castellanii: A new high-throughput method for drug screening in vitro.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Chlorhexidine; Colorimetry; Drug Evaluation, Preclinical; Humans; Oxazines; Xanthenes | 2016 |
Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Case-Control Studies; Chlorhexidine; Debridement; Disinfectants; Drug Therapy, Combination; Female; Humans; Keratoplasty, Penetrating; Male; Prognosis; Retrospective Studies; Visual Acuity | 2008 |
The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Base Sequence; Chlorhexidine; Contact Lens Solutions; Contact Lenses; Disinfectants; Humans; Molecular Sequence Data | 2008 |
Bilateral Acanthamoeba keratitis in Synergeyes contact lens wear: clinical and confocal microscopy findings.
Topics: Acanthamoeba Keratitis; Administration, Topical; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Chlorhexidine; Contact Lenses; Corneal Transplantation; Diagnosis, Differential; Diagnostic Errors; Female; Graft Rejection; Humans; Keratitis, Herpetic; Male; Microscopy, Confocal; Middle Aged; Retrospective Studies; Unnecessary Procedures; Young Adult | 2010 |
In vivo and in vitro laser confocal microscopy to diagnose acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Animals; Anti-Infective Agents, Local; Chlorhexidine; Cornea; Drug Therapy, Combination; Female; Humans; Lasers; Male; Microscopy, Confocal; Middle Aged; Tomography; Young Adult | 2010 |
Rapid detection of Acanthamoeba cysts in frozen sections of corneal scrapings with Fungiflora Y.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Chlorhexidine; Coloring Agents; Corneal Diseases; Epithelium, Corneal; Eye Infections, Parasitic; Frozen Sections; Humans; Organic Chemicals; Pyrimidines; Triazoles; Voriconazole | 2010 |
Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Biguanides; Chemotherapy, Adjuvant; Chlorhexidine; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Humans; Male; Microscopy, Confocal; Middle Aged; Photochemotherapy; Photosensitizing Agents; Riboflavin; Ultraviolet Rays; Visual Acuity | 2011 |
Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Chlorhexidine; Contact Lenses, Hydrophilic; Cornea; DNA, Protozoan; Drug Therapy, Combination; Female; Genotype; Humans; Middle Aged; Polymerase Chain Reaction; Spain | 2011 |
[Trailing the footpath of Acanthamoeba keratitis].
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Contact Lens Solutions; Contact Lenses, Hydrophilic; Disease Outbreaks; Disinfectants; Early Diagnosis; Humans | 2010 |
Utility of real-time polymerase chain reaction in diagnosing and treating acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Chlorhexidine; Contact Lenses, Hydrophilic; Cornea; DNA Copy Number Variations; DNA, Protozoan; Female; Humans; Male; Miconazole; Ophthalmic Solutions; Real-Time Polymerase Chain Reaction; Young Adult | 2011 |
Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Bacitracin; Chlorhexidine; Cornea; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Histocytochemistry; Male; Neomycin; Polymyxin B; Rats; Rats, Wistar; Treatment Outcome | 2012 |
Visual outcome in Japanese patients with Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Anti-Infective Agents, Local; Chlorhexidine; Female; Humans; Japan; Male; Middle Aged; Prognosis; Treatment Outcome; Visual Acuity; Young Adult | 2012 |
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Amebicides; Animals; Benzamidines; Biguanides; Chlorhexidine; Cornea; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parasitic Sensitivity Tests; Retrospective Studies; Risk Factors; Treatment Outcome | 2003 |
Acanthamoeba keratitis as a complication of orthokeratology.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Animals; Anti-Infective Agents; Chlorhexidine; Contact Lenses; Cornea; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Myopia; Neomycin | 2003 |
Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Atrophy; Benzamidines; Cataract; Cataract Extraction; Chlorhexidine; Drug Therapy, Combination; Female; Humans; Iris; Keratoplasty, Penetrating; Lens Implantation, Intraocular; Middle Aged; Visual Acuity | 2004 |
Biguanide-induced changes in Acanthamoeba castellanii: an electron microscopic study.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Cell Membrane; Chlorhexidine; Cytoplasm; Disinfectants; Humans; Life Cycle Stages; Microscopy, Electron; Microscopy, Electron, Scanning | 1998 |
Acanthamoeba keratitis during orthokeratology.
Topics: Acanthamoeba Keratitis; Adolescent; Antiprotozoal Agents; Benzamidines; Chlorhexidine; Contact Lenses; Cornea; Drug Therapy, Combination; Female; Humans; Myopia | 2005 |
Acanthamoeba keratitis: clinical characteristics and management.
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Anti-Infective Agents, Local; Antiprotozoal Agents; Cautery; Child; Chlorhexidine; Debridement; Drug Combinations; Early Diagnosis; Female; Humans; Male; Metronidazole; Middle Aged; Neomycin; Ophthalmic Solutions; Retrospective Studies; Risk Factors | 2006 |
Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Benzamidines; Child, Preschool; Chlorhexidine; Contact Lenses; Cornea; Drug Therapy, Combination; Glucocorticoids; Humans; Ketoconazole; Male; Prednisolone | 2006 |
Use of higher medication concentrations in the treatment of acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Humans | 2006 |
Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Anti-Infective Agents, Local; Antiprotozoal Agents; Cautery; Chlorhexidine; Debridement; Drug Combinations; Humans; Metronidazole; Neomycin; Ophthalmic Solutions; Risk Factors | 2006 |
Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Animals; Antiprotozoal Agents; Astigmatism; Biguanides; Chlorhexidine; Contact Lenses; Disinfectants; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Female; Humans; Itraconazole; Myopia; Parasitic Sensitivity Tests; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 18S; Sequence Analysis, DNA | 2006 |
Acanthamoeba keratitis related to orthokeratology.
Topics: Acanthamoeba Keratitis; Adolescent; Anti-Infective Agents, Local; Biguanides; Chlorhexidine; Circadian Rhythm; Contact Lenses; Drug Therapy, Combination; Female; Humans; Male; Visual Acuity | 2007 |
Acanthamoeba: keratopathogenicity of isolates from domestic tap water in Korea.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Cell Line; Chlorhexidine; Contact Lenses; Disinfectants; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Epithelium, Corneal; Fresh Water; Humans; Korea; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 18S; Sequence Analysis, DNA; Water Supply | 2007 |
The effect of propolis in experimental Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Animals; Anti-Infective Agents, Local; Antiprotozoal Agents; Cell Survival; Cells, Cultured; Chlorhexidine; Disease Models, Animal; Drug Therapy, Combination; Epithelium, Corneal; Propolis; Rats; Rats, Wistar | 2007 |
Acanthamoeba keratitis related to cosmetic contact lenses.
Topics: Acanthamoeba Keratitis; Adolescent; Antiprotozoal Agents; Biguanides; Chlorhexidine; Contact Lenses; Cosmetic Techniques; Drug Therapy, Combination; Female; Humans | 2007 |
Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine.
Topics: Acanthamoeba Keratitis; Administration, Topical; Antiprotozoal Agents; Chlorhexidine; Corneal Stroma; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Time Factors | 2008 |
Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Adult; Aged; Antiprotozoal Agents; Atrophy; Benzamidines; Biguanides; Cataract; Cataract Extraction; Chlorhexidine; Disease Progression; Disinfectants; Drug Therapy, Combination; Female; Glaucoma; Humans; Iris; Keratoplasty, Penetrating; Male; Middle Aged; Retrospective Studies; Trabeculectomy | 2008 |
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Biguanides; Chlorhexidine; Disinfectants; Humans; Ophthalmic Solutions | 1995 |
Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebicides; Animals; Benzamidines; Chlorhexidine; Drug Resistance; Drug Therapy, Combination; Humans; Male; Middle Aged | 1994 |
Treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Benzamidines; Chlorhexidine; Drug Therapy, Combination; Female; Humans | 1994 |
Chemotherapy for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Administration, Topical; Amebicides; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Drug Approval; Humans | 1995 |
Chemotherapy for acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Drug Therapy, Combination; Humans | 1995 |
Acanthamoeba griffini. Molecular characterization of a new corneal pathogen.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Antiprotozoal Agents; Base Sequence; Benzamidines; Chlorhexidine; Contact Lenses, Hydrophilic; Cornea; Disinfectants; Disposable Equipment; DNA, Protozoan; DNA, Ribosomal; Humans; Male; Molecular Sequence Data; Ophthalmic Solutions; Polymerase Chain Reaction; RNA, Ribosomal, 18S | 1996 |
Treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Chlorhexidine; Drug Therapy, Combination; Humans | 1996 |
Acanthamoeba keratitis: first recorded case from a Palestinian patient with trachoma.
Topics: Acanthamoeba Keratitis; Aged; Anti-Bacterial Agents; Benzamidines; Chlorhexidine; Drug Therapy, Combination; Female; Humans; Trachoma | 1996 |
Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Adolescent; Adult; Animals; Anti-Infective Agents; Antiprotozoal Agents; Benzamidines; Chlorhexidine; Contact Lenses; Female; Humans; Male; Microbiological Techniques; Middle Aged | 1996 |
Rational drug targeting in Acanthamoeba keratitis: implications of host cell-protozoan interaction.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Anti-Infective Agents, Local; Chlorhexidine; Cornea; Host-Parasite Interactions; Humans | 1997 |
The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Child; Child, Preschool; Chlorhexidine; Cornea; Culture Media; Disinfectants; Female; Humans; Male; Ophthalmic Solutions; Parasitic Sensitivity Tests | 2000 |
Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Biguanides; Chlorhexidine; Disinfectants; Dose-Response Relationship, Drug; Humans; Osmolar Concentration; Parasitic Sensitivity Tests; Time Factors | 2002 |